Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893113 · ClinicalTrials.gov registry record · Phase 3
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
A Phase 3 study of Erectile Dysfunction and Lower Urinary Tract Symptoms, sponsored by Chesapeake Urology Research Associates.
- Completed
- Registry status
- Phase 3
- Development phase
- 74
- Enrollment target
- 4
- Study locations
NCT00893113 is a Phase 3 study of Erectile Dysfunction and Lower Urinary Tract Symptoms that has completed, run by Chesapeake Urology Research Associates. The registered enrollment target is 74 participants, below the 229-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (68% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT00893113, a Phase 3 study of Erectile Dysfunction and Lower Urinary Tract Symptoms, has completed, sponsored by Chesapeake Urology Research Associates.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 74 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess the effect of Alfuzosin in treating Erectile Dysfunction in men with mild lower urinary tract symptoms based upon a change from baseline in erectile function (EF) domain of International Index of Erectile Function (IIEF).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Alfuzosin
Study Locations (4)
Maryland
- Chesapeake Urology Research Associates - Baltimore
- Chesapeake Urology Research Associates - Baltimore
- Chesapeake Urology Research Associates - Glen Burnie
- Chesapeake Urology Research Associates - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00893113
The ClinicalTrials.gov registry entry for NCT00893113 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (68% lower). The listed sponsor is Chesapeake Urology Research Associates, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00893113 reports 4 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00893113 about?
NCT00893113 is a clinical study titled "An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms". The purpose of this study is to assess the effect of Alfuzosin in treating Erectile Dysfunction in men with mild lower urinary tract symptoms based upon a change from baseline in erectile function (EF) domain of International Index of Erectile Function (IIEF).
What is the current status of trial NCT00893113?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 74 participants. The study started on 2009-06. Estimated completion is 2012-10.
What conditions does trial NCT00893113 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT00893113?
The interventions under investigation include: Placebo (DRUG), Alfuzosin (DRUG).
Who is sponsoring clinical trial NCT00893113?
This trial is sponsored by Chesapeake Urology Research Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00893113 being conducted?
This trial has 4 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RECRUITING · Phase 3
-
Actual Use Trial of Tadalafil 5 mg
RECRUITING · Phase 3
-
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
ACTIVE NOT RECRUITING · Phase 3
-
Treatment of Erectile Dysfunction II
COMPLETED · Phase 3
-
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
COMPLETED · Phase 3
-
Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.